AUVI - Applied UV gets initial purchase orders for Airocide air purification systems

Applied UV (AUVI) announces that it has received orders in excess of $850K for its Airocide consumer and commercial air purification systems from 3Sixty Biopharmaceuticals.3Sixty Biopharmaceuticals, the company's exclusive distributor within Africa, has agreed to an upfront binding purchase commitment of a minimum of $3.5M of Airocide systems over the initial one-year term of the agreement.The Airocide System is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst.Shares up marginally during premarket trading.

For further details see:

Applied UV gets initial purchase orders for Airocide air purification systems